Nanostics Launches Clinical Utility Study for Its AI-Powered ClarityDX Prostate Test to More Accurately Identify Aggressive Prostate Cancer
Press Releases
April 23, 2025

Nanostics Launches Clinical Utility Study for Its AI-Powered ClarityDX Prostate Test to More Accurately Identify Aggressive Prostate Cancer

The first patient was enrolled this month in a Nanostics-sponsored clinical utility study in Calgary to quantify the impact of incorporating ClarityDX Prostate into the standard of care for the

bradford

The Bradford Era

Local & Social